Health behaviors, body composition, and coronary heart disease risk in women with multiple sclerosis.

OBJECTIVES To explore coronary heart disease risk in a sample of women with multiple sclerosis (MS) by identifying the presence of established risk factors for coronary heart disease and to determine the relationship between disease severity and level of participation in health-related behaviors. DESIGN Survey study. SETTING Five general community settings in Oregon. PARTICIPANTS Women with physician-diagnosed MS (N=123) recruited from MS chapters, physician referrals, and newspaper announcements. INTERVENTIONS Not applicable. MAIN OUTCOME MEASURES Modified Yale Physical Activity Survey, Block Food Frequency Questionnaire, blood analysis, skinfolds, and waist and hip circumferences. RESULTS The majority of women met current physical activity guidelines. The frequencies of unfavorable levels of metabolic variables and obesity were similar to those reported in the general population. Significant associations were observed between mobility and physical activity, total and abdominal fat, and several dietary habits. CONCLUSION Coronary heart disease risk in this sample was comparable to that of the general population of women without MS. Physical inactivity, body composition, and perhaps nutritional habits decline with decreasing mobility, emphasizing the need for families and health care providers to work together to find solutions that increase health-promoting behaviors in women with more advanced MS.

[1]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[2]  S. Going,et al.  Estimation of body fat from skinfold thicknesses in middle‐aged and older men and women: A multiple component approach , 1992, American journal of human biology : the official journal of the Human Biology Council.

[3]  C. Caspersen,et al.  A survey for assessing physical activity among older adults. , 1993, Medicine and science in sports and exercise.

[4]  A. Astrup,et al.  Obesity : Preventing and managing the global epidemic , 2000 .

[5]  L. DiPietro.  The epidemiology of physical activity and physical function in older people. , 1996, Medicine and science in sports and exercise.

[6]  K. Patrick,et al.  Physical Activity and Public Health: A Recommendation From the Centers for Disease Control and Prevention and the American College of Sports Medicine , 1995 .

[7]  A. Wilcox,et al.  Coronary heart disease risk between active and inactive women with multiple sclerosis. , 2002, Medicine and science in sports and exercise.

[8]  A. King,et al.  Long-term effects of varying intensities and formats of physical activity on participation rates, fitness, and lipoproteins in men and women aged 50 to 65 years. , 1995, Circulation.

[9]  G. Spiller.  Handbook of Lipids in Human Nutrition , 1996 .

[10]  Charles Kooperberg,et al.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.

[11]  J. Petajan,et al.  Recommendations for Physical Activity in Patients with Multiple Sclerosis , 1999, Sports medicine.

[12]  N. Gordon,et al.  Women walking for health and fitness. How much is enough? , 1991, JAMA.

[13]  Michael Pratt,et al.  Levels of physical activity and inactivity in children and adults in the United States: current evidence and research issues. , 1999, Medicine and science in sports and exercise.

[14]  S Hulley,et al.  Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. , 1998, JAMA.

[15]  J. Kampert,et al.  Comparison of lifestyle and structured interventions to increase physical activity and cardiorespiratory fitness: a randomized trial. , 1999, JAMA.

[16]  Després Jp.  Visceral obesity, insulin resistance, and dyslipidemia: contribution of endurance exercise training to the treatment of the plurimetabolic syndrome. , 1997 .

[17]  G. Reaven,et al.  Pathophysiology of insulin resistance in human disease. , 1995, Physiological reviews.

[18]  M. Klag,et al.  Plasma lipoprotein levels as predictors of cardiovascular death in women. , 1993, Archives of internal medicine.

[19]  V. Fuster,et al.  Preventing heart attack and death in patients with coronary disease. , 1995, Circulation.

[20]  J. Mckenney,et al.  Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II) , 1993, JAMA.

[21]  Alexa Stuifbergen,et al.  Health promotion practices of women with multiple sclerosis. , 1997, Archives of physical medicine and rehabilitation.

[22]  G Block,et al.  Validation of a self-administered diet history questionnaire using multiple diet records. , 1990, Journal of clinical epidemiology.

[23]  Roger G. Mazlen,et al.  Nutrition and your health , 1979 .

[24]  Alexa Stuifbergen.  Health-Promoting Behaviors and Quality of Life Among Individuals With Multiple Sclerosis , 1995, Scholarly Inquiry for Nursing Practice.

[25]  A. Manley.  Physical Activity And Health: A Report Of The Surgeon General , 2004 .

[26]  G. Kraft,et al.  Disability, disease duration, and rehabilitation service needs in multiple sclerosis: patient perspectives. , 1986, Archives of physical medicine and rehabilitation.

[27]  J. Després,et al.  The insulin resistance-dyslipidemic syndrome: contribution of visceral obesity and therapeutic implications. , 1995, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[28]  J. Kent‐Braun,et al.  Quantitation of lower physical activity in persons with multiple sclerosis. , 1997, Medicine and science in sports and exercise.

[29]  M. Carroll,et al.  Overweight and obesity in the United States: prevalence and trends, 1960–1994 , 1998, International Journal of Obesity.

[30]  Susan R. Johnson,et al.  Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial , 1995 .

[31]  P. Williams,et al.  Physical activity and public health. , 1995, JAMA.

[32]  Alexa Stuifbergen,et al.  Health promotion: an essential component of rehabilitation for persons with chronic disabling conditions. , 1997, ANS. Advances in nursing science.

[33]  G A Colditz,et al.  Abdominal adiposity and coronary heart disease in women. , 1998, JAMA.

[34]  F. Pi‐Sunyer,et al.  Comorbidities of overweight and obesity: current evidence and research issues. , 1999, Medicine and science in sports and exercise.

[35]  T. Wadden,et al.  Effects of lifestyle activity vs structured aerobic exercise in obese women: a randomized trial. , 1999, JAMA.